1. |
Dong H, Zhu G, Tamada K,et al. B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med 1999; 5: 1365-9.
|
2. |
Sznol M, Chen L. Antagonist antibodies to PD-1 and B7-H1(PD-L1) in the treatment of advanced human cancer.D-L1) in the treatment of advanced human cancer. Clin Cancer Res 2013; 19: 1021-34.
|
3. |
Gao Q, Wang XY, Qiu SJ,et al. Overexpression of PD-L1 significantly associates with tumor aggressiveness and postoperative recurrence in human hepatocellular carci- noma. Clin Cancer Res 2009; 15: 971-9.
|
4. |
Gao Q, Qiu SJ, Fan J,et al. Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 2007; 25: 2586-93.
|
5. |
Bigelow E, Bever KM, Xu H,et al. Immunohistochemical staining of B7-H1(PD-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue.D-L1) on paraffin-embedded slides of pancreatic adenocarcinoma tissue. J Vis Exp 2013; 3: 4059.
|
6. |
Chen YB, Mu CY, Huang JA,et al. Clinical significance of programmed death-1 ligand-1 expression in patients with non-small cell lung cancer: A 5-year-follow-up study. Tumori 2012; 98: 751-5.
|
7. |
Zhang J, Shen KW, Liu G,et al. Antigen profiles of dissem- inated tumor cells and microenviromental characteristics in bone marrow of breast cancer. Eur J Surg Oncol 2003; 29: 121-6.
|
8. |
Fu XL, Zhu XZ, Shi DR,et al. Study of prognostic predictors for non-small cell lung cancer. Lung Cancer 1999; 23: 143-52.
|
9. |
Zhang Y, Huang S, Gong D,et al. Programmed death-1 up regulation is correlated with dysfunction of tumor-infiltrating CD8+ T lymphocytes in human non-small cell lung cancer. Cell Mol Immunol 2010; 7: 389-95.
|
10 |
Lin DY, Tanaka Y, Iwasaki M,et al. The PD-1/PD-L1 complex resembles the antigen-binding Fv domains of antibodies and T cell receptors. Proc Natl Acad Sci USA 2008; 105: 3011-6.
|
11 |
Yamazaki T, Akiba H, Iwai H,et al. Expression of programmed death 1 ligands by murine T cells and APC. J Immunol 2002; 169: 5538-45.
|
12 |
Mu CY, Huang JA, Chen Y,et al. High expression of PD-L1 in lung cancer may contribute to poor prognosis and tumor cells immune escape through suppressing tumor infiltrating dendritic cells maturation. Med Oncol 2011; 28: 682-8.
|
13 |
Konishi J, Yamazaki K, Azuma M,et al. B7-H1 expression on non-small cell lung cancer cells and its relationship with tumor-infiltrating lymphocytes and their PD-1 expression. Clin Cancer Res 2004; 10: 5094-100.
|
14 |
Wistuba I. Molecular changes in invasion, tumor progression and metastasis: M15-03. J Thorac Oncol 2007; 2: S192.
|